Indeed, FTY720 has been shown to inhibit the S1P-induced migration of classical Hodgkin lymphoma cells by modulating S1P1 expression and to reduce ovarian cancer cell migration by inhibiting SPHK1 [38,39]. Here, S1PR1 is linked to ovarian cancer.